UNSPSC 51131805: Etamsylate or ethamsylate

This classification denotes a hemostatic and benzenesulfonate with the molecular formula C6H6O5S.C4H11N, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 24YL531VOH, chemically known as 2,5-dihydroxybenzenesulfonic acid compound with diethylamine (1:1) but more generally known as etamsylate, which bears US NIH Compound Identifier 17506.

European Medicines Agency schedules Etamsylate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11943MIG World Health Organization schedules etamsylate in its Anatomical Therapeutic Chemical (ATC) Classification. ETAMSYLATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S(=O)(=O)(O)C1C(O)CCC(O)C1.N(CC)CC.

UNSPSC 51131805 Etamsylate or ethamsylate, a Commodity code, shows no recent state and local procurement activity aligned with its pharmaceutical scope. The single posted opportunity tagged to this code—Sourcewell RFP #061626, posted May 12, 2026 with a June 16, 2026 response deadline—solicits law enforcement equipment on behalf of a multi-jurisdictional cooperative purchasing group anchored by the State of Minnesota and including Franklin, Grant, Grays Harbor, Chelan, and Yakima Counties in Washington, along with other public entities nationwide. This mismatch between the code's nominal focus on a hemostatic pharmaceutical agent and the actual procurement of law enforcement equipment signals either a data-tagging error or highly irregular use of the code in state and local procurement systems.

The absence of relevant pharmaceutical solicitations under 51131805 limits visibility into issuing-body mix, geographic concentration, or substantive market activity for this commodity. Firms specializing in etamsylate or ethamsylate distribution should verify whether state and local health departments, hospital systems, or medical procurement consortiums use this code when soliciting hemostatic agents, or whether the code remains largely dormant in state and local systems in favor of alternative classification schemes. The law enforcement equipment RFP carries no direct signal for pharmaceutical vendors and should not be pursued under this code's mandate.